Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fei-Fei Tang

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Bone Marrow Transplantation|August 22, 2018
The significance of peri-transplantation minimal residual disease assessed by multiparameter flow cytometry on outcomes for adult AML patients receiving haploidentical allograftsJing Liu, Rui Ma, Yan-Rong Liu, et al.
Blood|May 25, 2022
An LSC-based MRD assay to complement the traditional MFC method for prediction of AML relapse: a prospective studySi-Qi Li, Lan-Ping Xu, Yu Wang, et al.
Bone Marrow Transplantation|May 4, 2022
Bulsufan decreases the incidence of mixed chimaerism in HLA-matched donor transplantation for severe aplastic anaemiaLan-Ping Xu, Zheng-Li Xu, Yuan-Yuan Zhang, et al.
British Journal of Haematology|November 6, 2021
Development and validation of a mortality predicting scoring system for severe aplastic anaemia patients receiving haploidentical allogeneic transplantationLan-Ping Xu, Yu Yu, Yi-Fei Cheng, et al.
Bone Marrow Transplantation|January 15, 2020
Impact of ABO incompatibility on outcomes after haploidentical hematopoietic stem cell transplantation for severe aplastic anemiaYan-Ru Ma, Wen-Jing Wang, Yi-Fei Cheng, et al.
Cytometry. Part B, Clinical Cytometry|August 20, 2019
The Quantification of Minimal Residual Disease Pre- and Post-Unmanipulated Haploidentical Allograft by Multiparameter Flow Cytometry in Pediatric Acute Lymphoblastic LeukemiaXin-Yu Wang, Qiao-Zhen Fan, Lan-Ping Xu, et al.
Chinese Medical Journal|December 5, 2018
Association of Persistent Minimal Residual Disease with Poor Outcomes of Patients with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Stem Cell TransplantationJing Liu, Xiao-Su Zhao, Yan-Rong Liu, et al.
Frontiers in Oncology|April 8, 2020
Different Effects of Pre-transplantation Measurable Residual Disease on Outcomes According to Transplant Modality in Patients With Philadelphia Chromosome Positive ALLSi-Qi Li, Qiao-Zhen Fan, Lan-Ping Xu, et al.
Current Medical Science|June 29, 2021
Predictive Value of Dynamic Peri-Transplantation MRD Assessed By MFC Either Alone or in Combination with Other Variables for Outcomes of Patients with T-Cell Acute Lymphoblastic LeukemiaZhi-Dong Wang, Yue-Wen Wang, Lan-Ping Xu, et al.
Chinese Medical Journal|March 18, 2021
A risk score system for stratifying the risk of relapse in B cell acute lymphocytic leukemia patients after allogenic stem cell transplantationLe-Qing Cao, Yang Zhou, Yan-Rong Liu, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Bone Marrow Transplantation|August 22, 2018
The significance of peri-transplantation minimal residual disease assessed by multiparameter flow cytometry on outcomes for adult AML patients receiving haploidentical allograftsJing Liu, Rui Ma, Yan-Rong Liu, et al.
Blood|May 25, 2022
An LSC-based MRD assay to complement the traditional MFC method for prediction of AML relapse: a prospective studySi-Qi Li, Lan-Ping Xu, Yu Wang, et al.
Bone Marrow Transplantation|May 4, 2022
Bulsufan decreases the incidence of mixed chimaerism in HLA-matched donor transplantation for severe aplastic anaemiaLan-Ping Xu, Zheng-Li Xu, Yuan-Yuan Zhang, et al.
British Journal of Haematology|November 6, 2021
Development and validation of a mortality predicting scoring system for severe aplastic anaemia patients receiving haploidentical allogeneic transplantationLan-Ping Xu, Yu Yu, Yi-Fei Cheng, et al.
Bone Marrow Transplantation|January 15, 2020
Impact of ABO incompatibility on outcomes after haploidentical hematopoietic stem cell transplantation for severe aplastic anemiaYan-Ru Ma, Wen-Jing Wang, Yi-Fei Cheng, et al.
Cytometry. Part B, Clinical Cytometry|August 20, 2019
The Quantification of Minimal Residual Disease Pre- and Post-Unmanipulated Haploidentical Allograft by Multiparameter Flow Cytometry in Pediatric Acute Lymphoblastic LeukemiaXin-Yu Wang, Qiao-Zhen Fan, Lan-Ping Xu, et al.
Chinese Medical Journal|December 5, 2018
Association of Persistent Minimal Residual Disease with Poor Outcomes of Patients with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Stem Cell TransplantationJing Liu, Xiao-Su Zhao, Yan-Rong Liu, et al.
Frontiers in Oncology|April 8, 2020
Different Effects of Pre-transplantation Measurable Residual Disease on Outcomes According to Transplant Modality in Patients With Philadelphia Chromosome Positive ALLSi-Qi Li, Qiao-Zhen Fan, Lan-Ping Xu, et al.
Current Medical Science|June 29, 2021
Predictive Value of Dynamic Peri-Transplantation MRD Assessed By MFC Either Alone or in Combination with Other Variables for Outcomes of Patients with T-Cell Acute Lymphoblastic LeukemiaZhi-Dong Wang, Yue-Wen Wang, Lan-Ping Xu, et al.
Chinese Medical Journal|March 18, 2021
A risk score system for stratifying the risk of relapse in B cell acute lymphocytic leukemia patients after allogenic stem cell transplantationLe-Qing Cao, Yang Zhou, Yan-Rong Liu, et al.
Pageof 6